Command Palette

Search for a command to run...

Asston Pharmaceuticals Ltd.
95(-3.06%)
1W: +1.55%

Asston Pharmaceuticals Peer Comparison

Snapshot Summary

Asston Pharmaceuticals Ltd. shows no growth metrics and lacks profitability indicators like ROE, ROA, and EBITDA margins, positioning it as a laggard in the sector. In contrast, peers such as Sun Pharmaceutical and Dr. Reddy's Laboratories demonstrate strong growth, profitability, and efficient capital utilization, while others like Divi's Laboratories struggle with declining revenues.

  • Asston Pharmaceuticals has zero revenue growth and no profitability metrics, indicating a lack of operational efficiency.
  • Sun Pharmaceutical and Dr. Reddy's Laboratories are sector leaders with high ROE, EPS, and growth metrics.
  • Divi's Laboratories shows concerning trends with negative revenue growth over three years.
  • Sun Pharmaceutical Industries Ltd.: Highest revenue growth YoY (8.42%) and 3-Year EPS growth (45.55).
  • Dr. Reddy's Laboratories Ltd.: Strong profitability with a ROE of 21.76% and solid revenue growth (16.54% YoY).
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Asston Pharmaceuticals Ltd.₹97.84₹83.28Cr19.26--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.